格洛布斯醫療有限公司
MX ˙ BMV ˙ US3795772082
SecurityMX:GMED / Globus Medical, Inc.
InstitutionRe Advisers Corp
Latest Disclosed Ownership76,325 shares
Latest Disclosed Value $ 6,576,162
Re Advisers Corp ownership in GMED / Globus Medical, Inc.

On May 8, 2026 - Re Advisers Corp filed a 13F-HR form disclosing ownership of 76,325 shares of Globus Medical, Inc. (MX:GMED) valued at $6,576,162 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 76,325 shares of Globus Medical, Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F GLOBUS MED CL A 379577208 76,325 0 0.00 6,576 -1.31 0.1766
2026-02-10 2025-12-31 13F GLOBUS MED CL A 379577208 76,325 0 0.00 6,664 52.44 0.1765
2025-11-05 2025-09-30 13F GLOBUS MED CL A 379577208 76,325 0 0.00 4,371 -2.95 0.1041
2025-08-05 2025-06-30 13F GLOBUS MED CL A 379577208 76,325 0 0.00 4,505 -19.37 0.1067
2025-05-06 2025-03-31 13F GLOBUS MED CL A 379577208 76,325 10,100 15.25 5,587 1.99 0.1368
2025-02-12 2024-12-31 13F GLOBUS MED CL A 379577208 66,225 0 0.00 5,477 15.62 0.1321
2024-11-01 2024-09-30 13F GLOBUS MED CL A 379577208 66,225 0 0.00 4,738 4.45 0.1127
2024-07-23 2024-06-30 13F GLOBUS MED CL A 379577208 66,225 0 0.00 4,536 27.67 0.1118
2024-05-10 2024-03-31 13F GLOBUS MED CL A 379577208 66,225 0 0.00 3,552 0.65 0.0833
2024-02-13 2023-12-31 13F GLOBUS MED CL A 379577208 66,225 0 0.00 3,529 7.33 0.0902
2023-11-09 2023-09-30 13F GLOBUS MED CL A 379577208 66,225 66,225 3,288 0.0913
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.